Here’s An Opinion On: Brisbane Winning Tenders Submitted by: M&A Critique Shares of Sun Pharma witnessed massive selling pressure, plunging over 16 percent after the drug major said it expects to take a hit on profit for the fiscal 2015-16 mainly due to integration process with Ranbaxy. The question which has been raised is as […]

Read More »